Literature DB >> 26002168

Preeclampsia: Short-term and Long-term Implications.

Jaimey M Pauli1, John T Repke2.   

Abstract

Preeclampsia is a hypertensive disorder that affects 4% of pregnancies and has a high risk of maternal, fetal, and neonatal morbidity and mortality, as well as long-term cardiovascular risk. Recent updates in the definition, diagnosis, and management guidelines for preeclampsia warrant review by general obstetrician-gynecologists. Screening and prevention algorithms for preeclampsia are available, but ultimately the cure remains delivery of the fetus and placenta. Close monitoring for the development and worsening of preeclampsia during pregnancy is essential to optimize both maternal and fetal/neonatal outcomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; Hypertension; Preeclampsia; Pregnancy; Prenatal screening

Mesh:

Substances:

Year:  2015        PMID: 26002168     DOI: 10.1016/j.ogc.2015.01.007

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  29 in total

Review 1.  A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Donatella Spotti; Franca Giacchino; Rossella Attini; Monica Limardo; Stefania Maxia; Antioco Fois; Linda Gammaro; Tullia Todros
Journal:  J Nephrol       Date:  2017-04-22       Impact factor: 3.902

2.  Hypertensive disorders of pregnancy increase the risk of developing neovascular age-related macular degeneration in later life.

Authors:  Karen Curtin; Lauren H Theilen; Alison Fraser; Ken R Smith; Michael W Varner; Gregory S Hageman
Journal:  Hypertens Pregnancy       Date:  2019-04-12       Impact factor: 2.108

3.  Expression of ADAMTS13 in Normal and Abnormal Placentae and Its Potential Role in Angiogenesis and Placenta Development.

Authors:  Juan Xiao; Yun Feng; Xueyin Li; Wei Li; Lei Fan; Jing Liu; Xue Zeng; Kaiyue Chen; Xi Chen; Xiaoshui Zhou; X Long Zheng; Suhua Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-27       Impact factor: 8.311

4.  Placental perfusion imaging using velocity-selective arterial spin labeling.

Authors:  Zungho Zun; Catherine Limperopoulos
Journal:  Magn Reson Med       Date:  2018-02-13       Impact factor: 4.668

5.  The associations between early pregnancy lipid profiles and pregnancy outcomes.

Authors:  C Wang; W Zhu; Y Wei; R Su; H Feng; E Hadar; M Hod; H Yang
Journal:  J Perinatol       Date:  2016-10-27       Impact factor: 2.521

6.  Trimester-specific plasma exosome microRNA expression profiles in preeclampsia.

Authors:  Eric Devor; Donna Santillan; Sabrina Scroggins; Akshaya Warrier; Mark Santillan
Journal:  J Matern Fetal Neonatal Med       Date:  2019-01-30

7.  Maternal morbidity and perinatal outcomes among women in rural versus urban areas.

Authors:  Sarka Lisonkova; Matthew D Haslam; Leanne Dahlgren; Innie Chen; Anne R Synnes; Kenneth I Lim
Journal:  CMAJ       Date:  2016-09-26       Impact factor: 8.262

8.  Cord blood irisin levels are positively correlated with birth weight in newborn infants.

Authors:  Kyoung Eun Joung; Kyung-Hee Park; Andreas Filippaios; Fadime Dincer; Helen Christou; Christos S Mantzoros
Journal:  Metabolism       Date:  2015-07-29       Impact factor: 8.694

9.  Downregulation of HIF-2α Enhances Apoptosis and Limits Invasion in Human Placental JEG-3 Trophoblast Cells.

Authors:  Yingying Xie; Haining Zhao; Pengli Luo; Meng Ma; Mengting Xu; Qin Li; Zhuojia Yang; Cenying He
Journal:  Reprod Sci       Date:  2021-05-24       Impact factor: 3.060

10.  Cytokine concentrations direct endothelial function in pregnancy and preeclampsia.

Authors:  Amanda K Mauro; Nauman Khurshid; Danielle M Berdahl; Amanda C Ampey; Daniel Adu; Dinesh M Shah; Derek S Boeldt
Journal:  J Endocrinol       Date:  2021-02       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.